![PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile](https://i1.rgstatic.net/publication/233699222_Diclofenac_sodium_01_ophthalmic_solution_Update_on_pharmacodynamics_clinical_interest_and_safety_profile/links/0f3175399f8f96e05a000000/largepreview.png)
PDF) Diclofenac sodium 0.1% ophthalmic solution: Update on pharmacodynamics, clinical interest and safety profile
![Pharmaceutics | Free Full-Text | Effects of Eye Drops Containing Hyaluronic Acid-Nimesulide Conjugates in a Benzalkonium Chloride-Induced Experimental Dry Eye Rabbit Model Pharmaceutics | Free Full-Text | Effects of Eye Drops Containing Hyaluronic Acid-Nimesulide Conjugates in a Benzalkonium Chloride-Induced Experimental Dry Eye Rabbit Model](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-01366/article_deploy/html/images/pharmaceutics-13-01366-g001.png?1630656450)
Pharmaceutics | Free Full-Text | Effects of Eye Drops Containing Hyaluronic Acid-Nimesulide Conjugates in a Benzalkonium Chloride-Induced Experimental Dry Eye Rabbit Model
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png?1662701546)